Corbion Bundle
Who Owns Corbion?
Understanding a company's ownership is key to grasping its strategic path and accountability. Corbion, a leader in bio-based ingredients, underwent a significant shift in 2013.
Previously known as CSM N.V., the company rebranded to Corbion to concentrate on its bio-based products, like lactic acid and its derivatives, after divesting its bakery supplies business. Its origins trace back to August 21, 1919, with a vision for sustainable, fermentation-driven solutions.
Corbion is a publicly traded entity on Euronext Amsterdam (CRBN). As of July 2025, its market capitalization stood at approximately $1.22 billion, supported by a global team of about 2,399 employees. The company's focus spans diverse industries, offering sustainable ingredients for food, personal care, animal nutrition, pharmaceuticals, and bioplastics, including innovations in Corbion PESTEL Analysis.
Who Founded Corbion?
The ownership of Corbion traces its roots back to its predecessor, Centrale Suiker Maatschappij (CSM) N.V., established in the Netherlands on August 21, 1919. Initially, CSM was structured as a holding company, with participating entities exchanging assets for shares. The early shareholding involved 100 preference shares and 12,000 regular shares, distributed among NV Wester Suikerraffinaderij, NV Hollandia Hollandsche Fabriek van Melkproducten en Voedingsmiddelen, and Firma Van Loon en Co.
| Entity | Regular Shares Held |
|---|---|
| NV Wester Suikerraffinaderij | 6,600 |
| NV Hollandia Hollandsche Fabriek van Melkproducten en Voedingsmiddelen | 4,200 |
| Firma Van Loon en Co | 1,200 |
CSM's Stock Exchange Listing
CSM N.V. became publicly traded when it was listed on the Amsterdam Stock Exchange in 1920. This marked a significant step in its corporate journey and accessibility for investors.
Diversification and Strategic Shift
Over the years, CSM's business evolved significantly. It gradually shifted its focus from sugar processing to encompass food and biochemicals, reflecting changing market demands and strategic foresight.
Acquisition of Caravan Products
A key acquisition was Caravan Products in 2003, a company with origins dating back to 1903 in the United States. This move was instrumental in building expertise in lactic-acid-based ingredients.
Formation of Caravan Ingredients
The merger of Caravan Products with American Ingredients in 2006 to form Caravan Ingredients was a pivotal moment. This consolidation strengthened the company's position in functional blends and emulsifiers.
Focus on Bio-based Activities
The strategic direction involved divesting non-core assets to concentrate on bio-based activities. This evolution laid the foundation for the company's current specialization.
Early Ownership Distribution
The initial shareholding structure reflected the contributions of the founding entities. This distribution of ownership was central to CSM's early corporate governance and operational framework.
The strategic vision of these early entities, particularly the move towards specialized ingredients, influenced the evolving distribution of control within CSM. As the company gradually divested non-core assets, its focus sharpened on bio-based activities, a direction that continues to shape its corporate identity and Growth Strategy of Corbion.
Key Milestones in Early Ownership and Strategy
The early history of Corbion's ownership is marked by significant strategic decisions and structural changes that guided its transformation from a sugar processor to a leader in bio-based ingredients.
- Establishment of CSM N.V. on August 21, 1919.
- Initial shareholding distribution among key participating companies.
- Listing on the Amsterdam Stock Exchange in 1920, making Corbion ownership publicly accessible.
- Strategic acquisition of Caravan Products in 2003, a move that expanded its ingredient portfolio.
- Formation of Caravan Ingredients in 2006, consolidating expertise in lactic acid derivatives.
- Gradual divestment of non-core assets to concentrate on bio-based business segments.
Corbion SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Corbion’s Ownership Changed Over Time?
Corbion's ownership structure saw a pivotal shift in 2013 when CSM N.V. divested its bakery supplies business, leading to its rebranding as Corbion and listing on Euronext Amsterdam. This strategic move repositioned the company as a focused entity in bio-based ingredients.
| Stakeholder | Percentage of Voting Rights | As of Date |
|---|---|---|
| NN Group N.V. | 15.24% | March 11, 2022 |
| Inclusive Capital Partners LLC | 10% | March 17, 2023 |
| Artemis Investment Management LLP | 5.28% | April 1, 2022 |
| Impax Asset Management Group Plc | 5.02% | August 23, 2023 |
| ASR Nederland N.V. | 4.99% | March 22, 2019 |
Corbion's journey as a dedicated bio-based ingredients company has been shaped by significant institutional ownership. As of July 2025, the company has approximately 58.4 million shares outstanding. Major stakeholders, as reported to the Dutch Authority for the Financial Markets (AFM) for holdings of 3% or more of voting rights, include NN Group N.V. with 15.24% as of March 11, 2022, and Inclusive Capital Partners LLC holding 10% as of March 17, 2023. Further diversification of its shareholder base is evident with Artemis Investment Management LLP at 5.28% (April 1, 2022) and Impax Asset Management Group Plc at 5.02% (August 23, 2023). ASR Nederland N.V. also maintains a notable stake of 4.99% as of March 22, 2019. These substantial institutional holdings suggest a strategic alignment towards long-term growth and operational enhancements, a direction reinforced by recent portfolio adjustments such as the divestment of the Emulsifiers business in 2024. Understanding the Competitors Landscape of Corbion can provide further context on the market forces influencing these ownership dynamics.
Key Institutional Investors in Corbion
Corbion's ownership is characterized by a strong presence of institutional investors, indicating confidence in its strategic direction.
- NN Group N.V. is a significant shareholder with 15.24% of voting rights.
- Inclusive Capital Partners LLC holds 10% of the voting rights.
- Artemis Investment Management LLP and Impax Asset Management Group Plc also represent substantial stakes.
- These holdings influence Corbion's strategic focus on sustainable growth.
Corbion PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Corbion’s Board?
Corbion N.V. operates as a Dutch public limited company, with its governance guided by the Dutch Civil Code, the Dutch Corporate Governance Code, its Articles of Association, and relevant securities laws. The company's shares are traded on Euronext Amsterdam, reflecting its public ownership structure.
| Governance Aspect | Details |
|---|---|
| Corporate Structure | Dutch public limited company |
| Primary Governance Frameworks | Dutch Civil Code, Dutch Corporate Governance Code, Articles of Association |
| Stock Exchange Listing | Euronext Amsterdam |
| Voting Principle | One-share-one-vote |
| Voting Restrictions | None |
| Decision Making (General Meeting) | Absolute majority of votes cast, no specific quorum unless law/articles dictate otherwise |
| Extraordinary General Meeting Request | Shareholders representing at least 10% of issued capital |
| Agenda Item Proposal | Shareholders representing at least 1% of issued capital (submitted 45 days prior) |
| Record Date for Voting Rights | 28 days prior to the meeting |
The voting power within Corbion is distributed based on a straightforward one-share-one-vote principle, meaning each share held directly translates to one vote. There are no limitations on how these voting rights can be exercised. For decisions made at the General Meeting of Shareholders, a simple majority of the votes cast is typically sufficient, without a mandatory quorum unless Dutch law or the company's own articles require a higher threshold for specific matters. Shareholders holding at least 10% of the company's issued capital have the authority to call for an extraordinary General Meeting. Additionally, a collective group of shareholders representing at least 1% of the issued capital can propose items for the General Meeting's agenda, provided they submit these proposals at least 45 days before the meeting date. The eligibility to vote is determined by a record date set 28 days before any shareholder meeting. Information regarding the current board members and their specific affiliations, such as major shareholders or independent directors, is usually detailed in the company's annual reports and investor relations materials. Understanding the Revenue Streams & Business Model of Corbion can provide further context on how these ownership and governance structures influence its operations.
Shareholder Influence and Rights
Shareholders play a crucial role in Corbion's governance, with specific rights to influence decision-making and company direction.
- Shareholders can propose agenda items for General Meetings.
- A significant minority can request extraordinary shareholder meetings.
- The one-share-one-vote system ensures proportional voting power.
- Information on major shareholders is publicly available in annual reports.
Corbion Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Corbion’s Ownership Landscape?
Recent developments at Corbion have significantly reshaped its strategic focus and financial outlook, impacting its ownership trends. The company has been actively streamlining its operations, evidenced by the divestment of its Emulsifiers business, which was completed in January 2024 for $362 million. This move underscores a commitment to concentrating on its core bio-based activities.
| Financial Metric | 2024 Value | Change/Trend |
|---|---|---|
| Annual Sales (Continuing Operations) | €1,288.1 million | Reflects strategic realignment |
| Adjusted EBITDA (Continuing Operations) | €175.0 million | 23.3% organic increase |
| Share Buyback | 992,483 shares (1.68% of capital) for €20 million | Capital allocation for shareholder value |
| Dividend per Ordinary Share | €0.64 | 5% increase, payable May 2025 |
Corbion's strategic direction is further highlighted by its share buyback program, which saw the repurchase of 992,483 shares, representing 1.68% of its capital, for €20 million as of April 26, 2024. This action reflects a proactive approach to capital management and enhancing shareholder returns. The company also approved a dividend of €0.64 per ordinary share for the financial year 2024, a 5% increase, scheduled for payment on May 27, 2025. These financial maneuvers are key indicators of how Corbion is managing its ownership interests and capital structure.
Focus on Core Business
The divestment of the Emulsifiers business for $362 million in January 2024 signals a clear intent to concentrate on bio-based innovations. This strategic shift is designed to strengthen the company's financial foundation and sharpen its market focus.
Shareholder Value Enhancement
Corbion's share buyback program and increased dividend payout demonstrate a commitment to returning value to its shareholders. These actions are crucial for maintaining investor confidence and optimizing the company's capital structure.
Leadership and Transparency
Executive committee changes in July 2025 aim to bolster leadership capabilities, supporting the company's forward-looking strategy. Furthermore, the publication of its first CSRD-compliant Annual Report in March 2025 enhances transparency for all stakeholders, providing a clearer view of Corbion ownership and operations.
Future Growth Projections
Looking ahead to fiscal year 2025, Corbion anticipates robust organic growth, with volume/mix expected between 2% and 6% and adjusted EBITDA organic growth exceeding 25%. The company also projects positive free cash flow exceeding €85 million, indicating strong operational performance and a positive outlook for Corbion company ownership and its financial trajectory. Understanding the Marketing Strategy of Corbion can provide further context on these growth drivers.
Corbion Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Corbion Company?
- What is Competitive Landscape of Corbion Company?
- What is Growth Strategy and Future Prospects of Corbion Company?
- How Does Corbion Company Work?
- What is Sales and Marketing Strategy of Corbion Company?
- What are Mission Vision & Core Values of Corbion Company?
- What is Customer Demographics and Target Market of Corbion Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.